Advertisement
The investor presentation by Patrick J. Balthrop, president and chiefexecutive officer, will begin at 11:00 a.m. Pacific time; 2:00 p.m. Easterntime on Tuesday, September 18, 2007. The presentation will be webcast liveand may be accessed at Luminex Corporation's website athttp://www.luminexcorp.com. Simply log on to the web at the address above, goto the Company section and access the Investor Relations link. Please go tothe website at least 15 minutes prior to the event to register, download andinstall any necessary audio/video software. If you are unable to participateduring the live webcast, the presentation will be archived for one year on thewebsite using the 'replay' link.
Advertisement
Luminex Corporation develops, manufactures and markets proprietarybiological testing technologies with applications throughout the life sciencesindustry. The Company's xMAP(R) system is an open-architecture, multi-analytetechnology platform that delivers fast, accurate and cost-effective bioassayresults to markets as diverse as pharmaceutical drug discovery, clinicaldiagnostics and biomedical research, including the genomics and proteomicsresearch markets. The Company's xMAP technology is sold worldwide and is inuse in leading research laboratories as well as major pharmaceutical,diagnostic and biotechnology companies. Further information on LuminexCorporation or xMAP can be obtained on the Internet athttp://www.luminexcorp.com.Contact: Harriss T. Currie Vice President, Finance and Chief Financial Officer 512-219-8020 [email protected]
SOURCE Luminex Corporation
